6Barronm D, Jimenez-lozanom E, Canom J, et al. Determination of residues of enrofloxacin and its metabolite ciprofloxaein in biological materials by capillary electrophoresis[J]. J Chromatogr B, 2001, 759( ): 73 - 79.
7Well M, Naber K G, Kinzig-schippers M, et al. Urinary bactericidal activity and pharmacokinetics of enoxacin versus norfloxacin and ciprofloxacin in healthy volunteers after a single oral dose[J]. Int J Antimicrob Agents, 1998, 10( ): 31 - 38.
8Nakashima M, kanamuru M, Uematu T, et al. Clinical pharmacokinetics and tolerance of fleroxacin in healthy male volunteers[J]. J Antimicrob Chemother, 1988, 22(Suppl D): 133 - 144.
9Boy D, Well M, Kinzig-schippers M, et al. Urinary bactericidal activity, urinary excretion and plasma concentrations of gatifloxacin versus ciprofloxacin in healthy volunteers after a single oral dose[J]. Int J Antimicrob Agents(Suppl) 2004, 23 (1):6-16.
10Pauliukonis L T, Missun D G, Bayne W F. Quantitation of norfloxacin, a new antibacterial agent in human plasma and urine by ion-pair reverse-phase chromatography[J]. J Pharm Sci, 1984, 73(1): 99 - 102.
